Learn more at LeadIQ.com

Insights

Cutting-Edge Immunotherapy TheraVectys is a biotechnology research company specializing in cutting-edge lentiviral vector technology for immunotherapy, offering innovative solutions for unmet medical needs in cancer and infectious diseases.

Recent Funding Boost TheraVectys recently secured a substantial $20 million in funding, signifying investor confidence in the company's technology and growth potential. This infusion of capital presents a prime opportunity for sales expansion and partnership development.

Key Personnel Appointment With the appointment of Alain Clergeot as Chief Executive Officer, TheraVectys showcases strategic leadership moves that could open avenues for strategic collaborations, new business ventures, and market visibility.

Proprietary Technology Platform TheraVectys leverages its proprietary lentiviral vector technology in collaboration with the prestigious Institut Pasteur, providing a unique and effective transfection mechanism for potent immune responses. This technological advantage offers a competitive edge for potential sales and partnerships.

Strategic Market Positioning In an industry landscape shared with companies like Theraclion, Valneva, and Innate Pharma, TheraVectys stands out with its focused approach on immunotherapy. This distinction presents sales opportunities for tailored solutions in a competitive market.

Similar companies to THERAVECTYS

THERAVECTYS Tech Stack

THERAVECTYS uses 8 technology products and services including WordPress Super Cache, MySQL, Twitter Emoji (Twemoji), and more. Explore THERAVECTYS's tech stack below.

WordPress Super Cache
Caching
MySQL
Database
Twitter Emoji (Twemoji)
Font Scripts
yepnope.js
Javascript Frameworks
Modernizr
Javascript Libraries
Google Maps
Maps
RSS
Miscellaneous
IIS
Web Servers

Media & News

THERAVECTYS's Email Address Formats

THERAVECTYS uses at least 1 format(s):

THERAVECTYS Email Formats	Example	Percentage
FLast@theravectys.com	JDoe@theravectys.com	44%
First.Last@theravectys.com	John.Doe@theravectys.com	11%
FMiddleLast@theravectys.com	JMichaelDoe@theravectys.com	1%
FLast@theravectys.com	JDoe@theravectys.com	44%

Frequently Asked Questions

Where is THERAVECTYS's headquarters located?

THERAVECTYS's main headquarters is located at 28, Rue du Docteur Roux Paris, Île-de-France 75015 FR. The company has employees across 2 continents, including EuropeNorth America.

What is THERAVECTYS's phone number?

You can contact THERAVECTYS's main corporate office by phone at

+33-1-43-90-1****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is THERAVECTYS's official website and social media links?

THERAVECTYS's official website is theravectys.com and has social profiles on LinkedIn.

How much revenue does THERAVECTYS generate?

As of June 2024, THERAVECTYS's annual revenue reached $3.8M.

What is THERAVECTYS's SIC code NAICS code?

THERAVECTYS's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does THERAVECTYS have currently?

As of June 2024, THERAVECTYS has approximately 18 employees across 2 continents, including EuropeNorth America. Key team members include Chief Medical Officer: C. B.Chief Representative: A. H.Trilingual Executive Assistant To Ceo: J. L.. Explore THERAVECTYS's employee directory with LeadIQ.

What industry does THERAVECTYS belong to?

THERAVECTYS operates in the Biotechnology Research industry.

What technology does THERAVECTYS use?

THERAVECTYS's tech stack includes WordPress Super CacheMySQLTwitter Emoji (Twemoji)yepnope.jsModernizrGoogle MapsRSSIIS.

What is THERAVECTYS's email format?

THERAVECTYS's email format typically follows the pattern of . Find more THERAVECTYS email formats with LeadIQ.

How much funding has THERAVECTYS raised to date?

As of June 2024, THERAVECTYS has raised $20M in funding. The last funding round occurred on Feb 08, 2021 for $20M.

When was THERAVECTYS founded?

THERAVECTYS was founded in 2005.

THERAVECTYS

THERAVECTYS

Biotechnology ResearchÎle-de-France, France11-50 Employees

Based in Paris and in the USA, TheraVectys is an immunotherapy company spun off from the Institut Pasteur created in 2005 by Dr. Pierre Charneau.

TheraVectys is pioneering the application of novel lentiviral vector technology to address most of unmet and critical medical needs.

By creating the only Joint-Laboratory between a private company and the Institut Pasteur in Paris, TheraVectys develops an extensive pipeline of vaccine candidates to drive the widespread treatment and prevention of cancer and infectious diseases.

Leveraging our proprietary technology platform, and the extensive virology expertise of the Institut Pasteur, TheraVectys provides a robust and highly effective transfection mechanism to elicit a potent and targeted immune response previously unseen.

Company Overview

Headquarters: 28, Rue du Docteur Roux Paris, Île-de-France 75015 FR
Phone number: ✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+33-1-43-90-1****
Website: theravectys.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2005
Employees: 11-50

Media & News

Funding & Financials

$20M
THERAVECTYS has raised a total of $20M of funding over 4 rounds. Their latest funding round was raised on Feb 08, 2021 in the amount of $20M.
$10M
THERAVECTYS's revenue is in the range of $10M

Funding & Financials

$20M
THERAVECTYS has raised a total of $20M of funding over 4 rounds. Their latest funding round was raised on Feb 08, 2021 in the amount of $20M.
$10M
THERAVECTYS's revenue is in the range of $10M

Company Leadership

C. B.
Chief Medical Officer
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. H.
Chief Representative
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. L.
Trilingual Executive Assistant To Ceo
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. L.
Trilingual Executive Assistant To CEO
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. B.
Senior VP, Business Development
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

E. B.
Clinical Operations Director
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. N.
Senior Scientist / Project Leader In Vaccine Development
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. S.
General Manager
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. T.
Senior Researcher In Car-T Cell Oncology Therapy, Project Manager
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. C.
General Manager
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.